High materiality7/10
BMO Capital Downgrades BioNTech (BNTX) to Market Perform
Why it may matterVerify against the original reporting
bearish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BNTX downgraded to Market Perform by BMO Capital; target $105; price $103.76.
- Downgraded to Market Perform; target $105 vs price $103.76.
Key facts
- 01
Target: $105
- 02
Posted price: $103.76
- 03
Analyst firm: BMO Capital
- 04
Analyst: Evan David Seigerman
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.